Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: Retrospective cohort study of an elderly population

Arthritis and Rheumatism

Volumn 43, Issue 4, 2000, Pages 917-924

  Rahme, Elham ^a   Joseph, Lawrence ^b   Kong, Sheldon X ^c   Watson, Douglas J ^c   Le Lorier, Jacques ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

AGED; ARTICLE; CANADA; DATA BASE; DRUG SAFETY; ELDERLY CARE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL;

ACETAMINOPHEN; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CANADA; COHORT STUDIES; DELIVERY OF HEALTH CARE; FEES, PHARMACEUTICAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; LOGISTIC MODELS; MALE; MISOPROSTOL; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033856811     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200004)43:4<917::AID-ANR25>3.0.CO;2-F     Document Type: Article

References (23)

1. NSAIDs gastropathy: A new understanding
2. Nonsteroidal anti-inflammatory drug and gastroenteropathy: The second hundred years
3. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis
4. ARAMIS and toxicity measurement
5. Gastrointestinal side-effects of nonsteroidal anti-inflammatory drugs
6. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: Is advanced age a risk factor?
7. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy
8. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
9. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
10. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: A Canadian consensus
11. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip
12. Guidelines for the management of rheumatoid arthritis
13. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen
14. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout
15. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs: A randomized double-blind placebo-controlled trial
16. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid suppression trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group
17. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs: Omeprazole versus Misoprostol for NSAID-Induced Ulcer Management (OMNIUM) Study Group
18. Cost of treating arthritis and NSAIDs-related gastrointestinal side-effects
19. The economic consequences of NSAID-induced gastropathy: The French context
20. Analysis of the costs of NSAIDs-associated gastropathy: Experience in a US health maintenance organisation
21. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec
22. A chronic disease score from automated pharmacy data
23. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data